\-\ Texto\\:\\ \ \(0\)\
\-\ recent\\ laboratory\\:\\ alkaline\\ phosphate\\ 301\\ u\\/l\\ \ \(0\)\
\-\ \\(normal\\ 38\\-126\\)\\,\\ other\\ basic\\ lab\\ results\\ normal\\.\ \(0\)\
\-\ tx\\:\\ biphosphonates\\ \\(older\\ tx\\ calcitonin\\)\ \(0\)\
\-\ focal\\ radiotracer\\ uptake\\ within\\ the\\ right\\ hemi\\-pelvis\\.\\ diffuse\\ radiotracer\\ uptake\\ within\\ the\\ right\\ shoulder\\ and\\ lower\\ lumbar\\ spine\\ consistent\\ with\\ degenerative\\ changes\\.\ \(0\)\
\-\ radiograph\\ of\\ the\\ pelvis\\ demonstrates\\ dense\\ sclerotic\\ trabeculae\\ and\\ lytic\\ areas\\ within\\ the\\ right\\ pelvis\\.\\ there\\ is\\ mild\\ cortical\\ expansion\\.\ \(0\)\
\-\ radiograph\\ of\\ the\\ skull\\ demonstrates\\ focal\\ lucency\\ across\\ the\\ anterior\\ portion\\ of\\ the\\ skull\\ consistent\\ with\\ osteoporosis\\ circumscripta\\.\ \(0\)\
\-\ paget\\ disease\\ of\\ bone\ \(0\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ arthritis\ \(395\)\
\-\ osteomyelitis\ \(170\)\
\-\ paget\\‚\\Ä\\ôs\\ disease\ \(0\)\
\-\ metabolic\\ dz\ \(0\)\
\-\ fibrous\\ dysplasia\\,\\ osteopetrosis\\,\\ osteogenesis\\ imperfecta\\,\\ melorheostosis\ \(0\)\
\-\ trauma\ \(1087\)\
\-\ 77\\ year\\ old\\ with\\ \\‚\\Ä\\úabnormal\\ prior\\ skull\\ radiograph\\‚\\Ä\\¶bone\\ pain\\‚\\Ä\\¶concern\\ for\\ metastatic\\ disease\\.\\‚\\Ä\\ù\ \(1\)\
\-\ disorder\\ of\\ middle\\-aged\\/older\\ individuals\\.\\ \\(3\\%\\ over\\ 40\\)\ \(0\)\
\-\ causes\\ bone\\ pain\\,\\ tenderness\\.\\ increased\\ risk\\ of\\ osteosarcoma\ \(0\)\
\-\ bony\\ proliferation\\ disease\\ characterized\\ by\\ excessive\\ and\\ abnormal\\ remodeling\\ of\\ bone\\:\\ sclerosis\\,\\ thickened\\ trabeculae\\,\\ and\\ enlargement\\.\ \(0\)\
\-\ 3\\ phases\\:\\ lytic\\,\\ mixed\\ lytic\\-sclerotic\\,\\ sclerotic\ \(0\)\
\-\ viral\\ etiology\\ has\\ been\\ considered\\.\ \(0\)\
\-\ elevated\\ alkaline\\ phosphatase\\,\\ 20\\%\\ monostotic\ \(0\)\
\-\ tx\\:\\ biphosphonates\\ \\(older\\ tx\\ calcitonin\\)\ \(0\)\
\-\ bone\\ scintigraphy\\:can\\ be\\ used\\ to\\ diagnose\\,\\ evaluate\\ extent\\,\\ and\\ evaluate\\ treatment\\ with\\ biphosphonates\\.\ \(0\)\
\-\ findings\\:\\ increased\\ uptake\\ along\\ cortico\\-medulary\\ bone\\,\\ sharp\\ leading\\ edge\\ \\‚\\Ä\\úflame\\-shaped\\‚\\Ä\\ù\\ or\\ \\‚\\Ä\\úblade\\-of\\-grass\\‚\\Ä\\ù\\,\\ bony\\ enlargement\\,\\ bowing\\ of\\ femur\\.\\ \ \(0\)\
\-\ location\\:\\ skull\\,\\ tubular\\ bones\\ \\(diaphysis\\)\\,\\ pelvis\\,\\ spine\\.\ \(0\)\
\-\ f\\-18\\-fdg\\ pet\\ not\\ helpful\\.\ \(0\)\
\-\ brown\\ ml\\.\\ bone\\ scintigraphy\\ in\\ benign\\ and\\ malignant\\ tumors\\.\\ radiol\\ clin\\ north\\ am\\ 31\\;731\\-738\\,\\ 1993\\.\ \(0\)\
\-\ hain\\ sf\\,\\ fogelman\\ i\\.\\ nuclear\\ medicine\\ studies\\ in\\ metabolic\\ bone\\ disease\\.\\ seminars\\ musculoskeletal\\ radiology\\ 6\\(4\\)\\;323\\-329\\,\\ 2002\\.\ \(0\)\
\-\ cook\\ gj\\,\\ maisey\\ mn\\,\\ fogelman\\ i\\.\\ fluorine\\-18\\-fdg\\ pet\\ in\\ paget\\‚\\Ä\\ôs\\ disease\\ of\\ bone\\.\\ j\\ nucl\\ med\\ 8\\(9\\)\\;1495\\-1497\\,\\ 1997\\.\ \(0\)\
\-\ resnick\\ d\\,\\ kransdorf\\ mj\\.\\ bone\\ and\\ joint\\ imaging\\.\\ 3rd\\ edition\\,\\ elsevier\\-saunders\\.\\ 576\\-588\\,\\ 2005\\.\ \(0\)\
\-\ thrall\\ jh\\,\\ ziessman\\ ha\\.\\ nuclear\\ medicine\\:\\ the\\ requisites\\.\\ 2nd\\ ed\\.\\,\\ mosby\\.chapter\\ 6\\,\\ 2001\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ biphosphonates\\:\\ 0\\.07052414739173199\ \(0\)\
\-\ tx\\:\\ 0\\.05641768425973692\ \(0\)\
\-\ bone\\:\\ 0\\.05096243235503688\ \(0\)\
\-\ fogelman\\:\\ 0\\.04701609826115465\ \(0\)\
\-\ skull\\:\\ 0\\.03881993270818847\ \(0\)\
\-\ paget\\:\\ 0\\.03790384784048623\ \(0\)\
\-\ calcitonin\\:\\ 0\\.03592574337219553\ \(0\)\
\-\ trabeculae\\:\\ 0\\.03160078221904178\ \(0\)\
\-\ i\\.\\:\\ 0\\.031038859468866704\ \(0\)\
\-\ alkaline\\:\\ 0\\.029057187167893458\ \(0\)\
\-\ uptake\\:\\ 0\\.0271598673975537\ \(0\)\
\-\ \\:\\:\\ 0\\.02712659558377596\ \(0\)\
\-\ scintigraphy\\:\\ 0\\.026481977718701012\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.02553200734223328\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.025388890824227076\ \(0\)\
\-\ pelvis\\:\\ 0\\.02484073125273303\ \(0\)\
\-\ pet\\:\\ 0\\.023918853779627557\ \(0\)\
\-\ nuclear\\:\\ 0\\.02351359560907864\ \(0\)\
\-\ hemi\\-pelvis\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ radiograph\\‚\\Ä\\¶bone\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ pain\\‚\\Ä\\¶concern\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ disease\\.\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ middle\\-aged\\/older\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ lytic\\-sclerotic\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ cortico\\-medulary\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ f\\-18\\-fdg\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ 731\\-738\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ hain\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ 323\\-329\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ maisey\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ fluorine\\-18\\-fdg\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ 1495\\-1497\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ elsevier\\-saunders\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ 576\\-588\\:\\ 0\\.023508049130577326\ \(0\)\
\-\ older\\:\\ 0\\.02295818089306479\ \(0\)\
\-\ metabolic\\:\\ 0\\.02250879239377018\ \(0\)\
\-\ disease\\:\\ 0\\.022347800659451265\ \(0\)\
\-\ 301\\:\\ 0\\.02165965664908414\ \(0\)\
\-\ blade\\-of\\-grass\\:\\ 0\\.02165965664908414\ \(0\)\
\-\ cook\\:\\ 0\\.02165965664908414\ \(0\)\
\-\ mosby\\.chapter\\:\\ 0\\.02165965664908414\ \(0\)\
\-\ \\,\\:\\ 0\\.02165680524138299\ \(0\)\
\-\ medicine\\:\\ 0\\.021617837275566622\ \(0\)\
\-\ radiotracer\\:\\ 0\\.02126509166220905\ \(0\)\
\-\ sf\\:\\ 0\\.0205784163607957\ \(0\)\
\-\ sclerotic\\:\\ 0\\.02040045779833473\ \(0\)\
\-\ lytic\\:\\ 0\\.02040045779833473\ \(0\)\
\-\ circumscripta\\:\\ 0\\.019811264167590954\ \(0\)\
\-\ flame\\-shaped\\:\\ 0\\.019811264167590954\ \(0\)\
\-\ 1993\\.\\:\\ 0\\.019811264167590954\ \(0\)\
\-\ seminars\\:\\ 0\\.019811264167590954\ \(0\)\
\-\ kransdorf\\:\\ 0\\.019811264167590954\ \(0\)\
\-\ gj\\:\\ 0\\.01921621469741973\ \(0\)\
\-\ mn\\:\\ 0\\.01921621469741973\ \(0\)\
\-\ nucl\\:\\ 0\\.018730023879302515\ \(0\)\
\-\ 1997\\.\\:\\ 0\\.018730023879302515\ \(0\)\
\-\ mj\\:\\ 0\\.018730023879302515\ \(0\)\
\-\ evaluate\\:\\ 0\\.018422540044037723\ \(0\)\
\-\ melorheostosis\\:\\ 0\\.018318955399763158\ \(0\)\
\-\ 2005\\.\\:\\ 0\\.018318955399763158\ \(0\)\
\-\ bony\\:\\ 0\\.01822589718639331\ \(0\)\
\-\ enlargement\\:\\ 0\\.01808303150125384\ \(0\)\
\-\ monostotic\\:\\ 0\\.017962871686097764\ \(0\)\
\-\ ziessman\\:\\ 0\\.017962871686097764\ \(0\)\
\-\ osteopetrosis\\:\\ 0\\.017648783591014076\ \(0\)\
\-\ thrall\\:\\ 0\\.017648783591014076\ \(0\)\
\-\ 38\\-126\\:\\ 0\\.01736782221592654\ \(0\)\
\-\ ed\\.\\:\\ 0\\.01736782221592654\ \(0\)\
\-\ phosphate\\:\\ 0\\.01711366173644834\ \(0\)\
\-\ dz\\:\\ 0\\.016668184177346564\ \(0\)\
\-\ 2002\\.\\:\\ 0\\.01647056291826997\ \(0\)\
\-\ jh\\:\\ 0\\.01647056291826997\ \(0\)\
\-\ \\;\\:\\ 0\\.01620336950762075\ \(0\)\
\-\ radiol\\:\\ 0\\.016114479204604577\ \(0\)\
\-\ resnick\\:\\ 0\\.015952813546427417\ \(0\)\
\-\ ml\\:\\ 0\\.01580039110952089\ \(0\)\
\-\ osteogenesis\\:\\ 0\\.015265269254955152\ \(0\)\
\-\ imperfecta\\:\\ 0\\.015265269254955152\ \(0\)\
\-\ north\\:\\ 0\\.01514673122143293\ \(0\)\
\-\ ha\\:\\ 0\\.01514673122143293\ \(0\)\
\-\ brown\\:\\ 0\\.015033238916316138\ \(0\)\
\-\ spine\\:\\ 0\\.015008552245361855\ \(0\)\
\-\ phases\\:\\ 0\\.014924380264262125\ \(0\)\
\-\ phosphatase\\:\\ 0\\.014924380264262125\ \(0\)\
\-\ requisites\\:\\ 0\\.01471915082123245\ \(0\)\
\-\ bowing\\:\\ 0\\.014622170436776783\ \(0\)\
\-\ basic\\:\\ 0\\.014528593583946729\ \(0\)\
\-\ radiograph\\:\\ 0\\.0145170594875806\ \(0\)\
\-\ remodeling\\:\\ 0\\.014438189446144913\ \(0\)\
\-\ diagnose\\:\\ 0\\.014438189446144913\ \(0\)\
\-\ u\\/l\\:\\ 0\\.013878934696859396\ \(0\)\
\-\ 77\\:\\ 0\\.013878934696859396\ \(0\)\
\-\ osteoporosis\\:\\ 0\\.013807819371306967\ \(0\)\
\-\ excessive\\:\\ 0\\.013807819371306967\ \(0\)\
\-\ proliferation\\:\\ 0\\.013738551407564938\ \(0\)\
\-\ \\‚\\Ä\\ô\\:\\ 0\\.013621475944775764\ \(0\)\
\-\ 6\\:\\ 0\\.013611307527332663\ \(0\)\
\-\ edition\\:\\ 0\\.013605190286032506\ \(0\)\
\-\ \\(\\:\\ 0\\.013484085556552065\ \(0\)\
\-\ clin\\:\\ 0\\.013416876773461964\ \(0\)\
\-\ \\)\\:\\ 0\\.013319370252781695\ \(0\)\
\-\ individuals\\:\\ 0\\.013298338739939741\ \(0\)\
\-\ med\\:\\ 0\\.013075987782768937\ \(0\)\
\-\ s\\:\\ 0\\.013070760891277797\ \(0\)\
\-\ within\\:\\ 0\\.013041051267088653\ \(0\)\
\-\ focal\\:\\ 0\\.013015965888738143\ \(0\)\
\-\ abnormal\\:\\ 0\\.012997825281679526\ \(0\)\
\-\ edge\\:\\ 0\\.012773777955283595\ \(0\)\
\-\ sharp\\:\\ 0\\.012335636485173525\ \(0\)\
\-\ diaphysis\\:\\ 0\\.012256028583441042\ \(0\)\
\-\ across\\:\\ 0\\.01217872848511237\ \(0\)\
\-\ 2001\\:\\ 0\\.012103606146534515\ \(0\)\
\-\ 31\\:\\ 0\\.011959426889813779\ \(0\)\
\-\ musculoskeletal\\:\\ 0\\.01192456800563417\ \(0\)\
\-\ osteosarcoma\\:\\ 0\\.011856188190665272\ \(0\)\
\-\ helpful\\:\\ 0\\.011789518051450823\ \(0\)\
\-\ am\\:\\ 0\\.011724474176453066\ \(0\)\
\-\ viral\\:\\ 0\\.011479090446532395\ \(0\)\
\-\ metastatic\\:\\ 0\\.011472583485952481\ \(0\)\
\-\ d\\:\\ 0\\.011364377419642554\ \(0\)\
\-\ 2nd\\:\\ 0\\.011364377419642554\ \(0\)\
\-\ characterized\\:\\ 0\\.011336453953329766\ \(0\)\
\-\ extent\\:\\ 0\\.011308819854568308\ \(0\)\
\-\ 3rd\\:\\ 0\\.011281469187455803\ \(0\)\
\-\ expansion\\:\\ 0\\.01122759530127575\ \(0\)\
\-\ consistent\\:\\ 0\\.011174924100433083\ \(0\)\
\-\ increased\\:\\ 0\\.011149252169598164\ \(0\)\
\-\ lab\\:\\ 0\\.011148771828631632\ \(0\)\
\-\ leading\\:\\ 0\\.010901681614011087\ \(0\)\
\-\ dense\\:\\ 0\\.01076371981561325\ \(0\)\
\-\ 3\\:\\ 0\\.010671869475768212\ \(0\)\
\-\ \\%\\:\\ 0\\.010631045511178707\ \(0\)\
\-\ tubular\\:\\ 0\\.010611297378706721\ \(0\)\
\-\ osteomyelitis\\:\\ 0\\.010590216900021085\ \(0\)\
\-\ lucency\\:\\ 0\\.010467118121985985\ \(0\)\
\-\ degenerative\\:\\ 0\\.010330336003619184\ \(0\)\
\-\ j\\:\\ 0\\.0102925103103073\ \(0\)\
\-\ disorder\\:\\ 0\\.01023675915078913\ \(0\)\
\-\ thickened\\:\\ 0\\.010218431472688432\ \(0\)\
\-\ mixed\\:\\ 0\\.010007795709172084\ \(0\)\
\-\ demonstrates\\:\\ 0\\.009955313075483658\ \(0\)\
\-\ femur\\:\\ 0\\.00984414518550197\ \(0\)\
\-\ arthritis\\:\\ 0\\.009735286533447959\ \(0\)\
\-\ lumbar\\:\\ 0\\.009689959663131768\ \(0\)\
\-\ etiology\\:\\ 0\\.009645390380535126\ \(0\)\
\-\ radiology\\:\\ 0\\.009630697965039207\ \(0\)\
\-\ bones\\:\\ 0\\.00961608605633354\ \(0\)\
\-\ 40\\:\\ 0\\.009587100263701796\ \(0\)\
\-\ 9\\:\\ 0\\.009419505853942692\ \(0\)\
\-\ fibrous\\:\\ 0\\.009211270022018861\ \(0\)\
\-\ results\\:\\ 0\\.009198779757185725\ \(0\)\
\-\ considered\\:\\ 0\\.009198779757185725\ \(0\)\
\-\ shoulder\\:\\ 0\\.009186347722236895\ \(0\)\
\-\ dysplasia\\:\\ 0\\.008994935235852545\ \(0\)\
\-\ causes\\:\\ 0\\.008870881860826164\ \(0\)\
\-\ used\\:\\ 0\\.008741824418527897\ \(0\)\
\-\ tumors\\:\\ 0\\.00855924362045467\ \(0\)\
\-\ 8\\:\\ 0\\.008520313488664928\ \(0\)\
\-\ studies\\:\\ 0\\.00851066911407776\ \(0\)\
\-\ laboratory\\:\\ 0\\.00839757796227751\ \(0\)\
\-\ cortical\\:\\ 0\\.008306866268202165\ \(0\)\
\-\ portion\\:\\ 0\\.008253884392957564\ \(0\)\
\-\ risk\\:\\ 0\\.008253884392957564\ \(0\)\
\-\ malignant\\:\\ 0\\.008236455137011468\ \(0\)\
\-\ 20\\:\\ 0\\.008193373963085376\ \(0\)\
\-\ sclerosis\\:\\ 0\\.008184840622470253\ \(0\)\
\-\ location\\:\\ 0\\.007948553831743714\ \(0\)\
\-\ benign\\:\\ 0\\.007864134312088537\ \(0\)\
\-\ elevated\\:\\ 0\\.007731510296957501\ \(0\)\
\-\ areas\\:\\ 0\\.007667592456656178\ \(0\)\
\-\ recent\\:\\ 0\\.007660584130239459\ \(0\)\
\-\ along\\:\\ 0\\.007530810338289376\ \(0\)\
\-\ joint\\:\\ 0\\.007369144680112216\ \(0\)\
\-\ right\\:\\ 0\\.007213053672883334\ \(0\)\
\-\ normal\\:\\ 0\\.007144599757861872\ \(0\)\
\-\ tenderness\\:\\ 0\\.006930432861017689\ \(0\)\
\-\ diffuse\\:\\ 0\\.006898686454334173\ \(0\)\
\-\ changes\\:\\ 0\\.0065307946032934945\ \(0\)\
\-\ 4\\:\\ 0\\.006349258413810787\ \(0\)\
\-\ trauma\\:\\ 0\\.0062320234180211435\ \(0\)\
\-\ been\\:\\ 0\\.006199453038570643\ \(0\)\
\-\ mild\\:\\ 0\\.006000675877149698\ \(0\)\
\-\ anterior\\:\\ 0\\.0058687808633673\ \(0\)\
\-\ prior\\:\\ 0\\.005850967392539636\ \(0\)\
\-\ over\\:\\ 0\\.005801713573706567\ \(0\)\
\-\ imaging\\:\\ 0\\.005338863531881607\ \(0\)\
\-\ other\\:\\ 0\\.005252369463206529\ \(0\)\
\-\ can\\:\\ 0\\.0051685929399175184\ \(0\)\
\-\ lower\\:\\ 0\\.005124965518303633\ \(0\)\
\-\ findings\\:\\ 0\\.004850231828773225\ \(0\)\
\-\ treatment\\:\\ 0\\.004612311892269032\ \(0\)\
\-\ has\\:\\ 0\\.004279199921318074\ \(0\)\
\-\ by\\:\\ 0\\.003794322408652999\ \(0\)\
\-\ be\\:\\ 0\\.003514017928917144\ \(0\)\
\-\ there\\:\\ 0\\.0033912414839066362\ \(0\)\
\-\ in\\:\\ 0\\.0033711778411220396\ \(0\)\
\-\ and\\:\\ 0\\.0033601681070014114\ \(0\)\
\-\ not\\:\\ 0\\.0032928497913118277\ \(0\)\
\-\ the\\:\\ 0\\.00294931807367735\ \(0\)\
\-\ of\\:\\ 0\\.0027960912191517225\ \(0\)\
\-\ pain\\:\\ 0\\.0027829551134152925\ \(0\)\
\-\ or\\:\\ 0\\.0026707273305698865\ \(0\)\
\-\ year\\:\\ 0\\.002549614051394439\ \(0\)\
\-\ old\\:\\ 0\\.0023331589249660123\ \(0\)\
\-\ \\.\\:\\ 0\\.0022719703102301618\ \(0\)\
\-\ for\\:\\ 0\\.0019442883963805735\ \(0\)\
\-\ is\\:\\ 0\\.0014994420756926016\ \(0\)\
\-\ with\\:\\ 0\\.0012480445449588237\ \(0\)\
\-\ to\\:\\ 0\\.0011388482891812966\ \(0\)\
